Clinical Trial Update: Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study

View source ↗

Summary

A Singapore-based cohort study called Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease (RESET) is investigating immune, lipid, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Metabolic Syndrome
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Cardiovascular Diseases, Metabolic Syndrome | Status: RECRUITING